Related Experiment Video
Updated: Jul 14, 2026
05:10
Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
Published on: December 11, 2016
Structure-based strategies for drug design and discovery.
1Department of Pharmaceutical Chemistry, School of Pharmacy, University of California, San Francisco 94143.
Science (New York, N.Y.)
|August 21, 1992
Summary
Structure-based drug design uses molecular structures and computer programs to create new medicines. This approach is advancing therapeutic agent development for diseases like acquired immunodeficiency syndrome (AIDS) and bacterial drug resistance.
Area of Science:
- Biochemistry
- Computational Chemistry
- Drug Discovery
Background:
- Traditional drug discovery relies on random screening or understanding macromolecular receptors.
- Molecular structures of proteins and nucleic acids provide crucial information for drug design.
Purpose of the Study:
- To explore the application of structure-based drug design in developing novel therapeutic agents.
- To highlight the role of computational methods in conjunction with structural data for drug development.
- To investigate the potential of this approach for acquired immunodeficiency syndrome (AIDS) and bacterial drug resistance.
Main Methods:
- Utilizing molecular structure determination (e.g., X-ray crystallography, NMR spectroscopy).
- Employing specialized computer programs for in silico drug design and virtual screening.
- Implementing iterated design cycles for compound optimization.
Main Results:
- Successful proposal of novel enzyme inhibitors and therapeutic agents.
- Development of compounds that have progressed to clinical trials.
- Demonstration of the synergy between structural biology and computational chemistry.
Conclusions:
- Structure-based drug design, integrating molecular structure determination and computation, is a powerful tool for modern drug development.
- This integrated approach shows significant promise for addressing critical health challenges such as AIDS and antibiotic resistance.
Related Concept Videos
01:26Drug Discovery: Overview
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
01:24Principles of Drug Action
Drugs are chemical substances that modify biological responses by interacting with macromolecular targets such as receptors, ion channels, transporters, and enzymes. Pharmacodynamics describes the course of action of drugs leading to the physiological effect at a specific site in the body.
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
01:28Biopharmaceutics and Pharmacokinetics: Overview
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the appropriate...
01:28Structure-Activity Relationships and Drug Design
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
01:26Drug Administration and Therapy Phases: Overview
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
01:22Biopharmaceutical Factors Influencing Drug Product Design: Overview
Rational drug product design integrates knowledge of the drug’s physicochemical properties, formulation components, manufacturing techniques, and intended route of administration. Each factor influences the drug’s performance, including how it is released, absorbed, and eliminated in the body.The physicochemical properties of a drug—such as solubility, stability, and particle size—affect its compatibility with excipients and the choice of dosage form. Excipients, though pharmacologically...